Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux.

NCT01233843 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

370

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Head and Neck Carcinoma

Interventions

DRUG: carboplatin
DRUG: 5 fluorouracil
RADIATION: radiation therapy

Sponsor

Groupe Oncologie Radiotherapie Tete et Cou